221 related articles for article (PubMed ID: 28693586)
1. Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy.
Goswami M; Prince G; Biancotto A; Moir S; Kardava L; Santich BH; Cheung F; Kotliarov Y; Chen J; Shi R; Zhou H; Golding H; Manischewitz J; King L; Kunz LM; Noonan K; Borrello IM; Smith BD; Hourigan CS
J Transl Med; 2017 Jul; 15(1):155. PubMed ID: 28693586
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia.
Sander FE; Rydström A; Bernson E; Kiffin R; Riise R; Aurelius J; Anderson H; Brune M; Foà R; Hellstrand K; Thorén FB; Martner A
Oncotarget; 2016 Feb; 7(7):7586-96. PubMed ID: 26863635
[TBL] [Abstract][Full Text] [Related]
3. A subset of virus-specific CD161
Alsuliman A; Muftuoglu M; Khoder A; Ahn YO; Basar R; Verneris MR; Muranski P; Barrett AJ; Liu E; Li L; Stringaris K; Armstrong-James D; Shaim H; Kondo K; Imahashi N; Andersson B; Marin D; Champlin RE; Shpall EJ; Rezvani K
Blood; 2017 Feb; 129(6):740-758. PubMed ID: 27821506
[TBL] [Abstract][Full Text] [Related]
4. Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions.
Rosenblatt J; Stone RM; Uhl L; Neuberg D; Joyce R; Levine JD; Arnason J; McMasters M; Luptakova K; Jain S; Zwicker JI; Hamdan A; Boussiotis V; Steensma DP; DeAngelo DJ; Galinsky I; Dutt PS; Logan E; Bryant MP; Stroopinsky D; Werner L; Palmer K; Coll M; Washington A; Cole L; Kufe D; Avigan D
Sci Transl Med; 2016 Dec; 8(368):368ra171. PubMed ID: 27928025
[TBL] [Abstract][Full Text] [Related]
5. A skewed distribution and increased PD-1+Vβ+CD4+/CD8+ T cells in patients with acute myeloid leukemia.
Huang J; Tan J; Chen Y; Huang S; Xu L; Zhang Y; Lu Y; Yu Z; Chen S; Li Y
J Leukoc Biol; 2019 Sep; 106(3):725-732. PubMed ID: 31136687
[TBL] [Abstract][Full Text] [Related]
6. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment.
Schnorfeil FM; Lichtenegger FS; Emmerig K; Schlueter M; Neitz JS; Draenert R; Hiddemann W; Subklewe M
J Hematol Oncol; 2015 Jul; 8():93. PubMed ID: 26219463
[TBL] [Abstract][Full Text] [Related]
7. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.
Haralambieva IH; Painter SD; Kennedy RB; Ovsyannikova IG; Lambert ND; Goergen KM; Oberg AL; Poland GA
PLoS One; 2015; 10(3):e0122282. PubMed ID: 25816015
[TBL] [Abstract][Full Text] [Related]
8. Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy.
Knaus HA; Berglund S; Hackl H; Blackford AL; Zeidner JF; Montiel-Esparza R; Mukhopadhyay R; Vanura K; Blazar BR; Karp JE; Luznik L; Gojo I
JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385732
[TBL] [Abstract][Full Text] [Related]
9. Interferon-induced programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment.
Krönig H; Kremmler L; Haller B; Englert C; Peschel C; Andreesen R; Blank CU
Eur J Haematol; 2014 Mar; 92(3):195-203. PubMed ID: 24175978
[TBL] [Abstract][Full Text] [Related]
10. The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50- to 74-year-old adults.
Kennedy RB; Simon WL; Gibson MJ; Goergen KM; Grill DE; Oberg AL; Poland GA
Immunology; 2016 Jul; 148(3):266-75. PubMed ID: 27188667
[TBL] [Abstract][Full Text] [Related]
11. Keeping the memory of influenza viruses.
Combadière B; Sibéril S; Duffy D
Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
[TBL] [Abstract][Full Text] [Related]
12. Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy.
Royer PJ; Bougras G; Ebstein F; Leveque L; Tanguy-Royer S; Simon T; Juge-Morineau N; Chevallier P; Harousseau JL; Gregoire M
Exp Hematol; 2008 Mar; 36(3):329-39. PubMed ID: 18207305
[TBL] [Abstract][Full Text] [Related]
13. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.
Hanitsch LG; Löbel M; Mieves JF; Bauer S; Babel N; Schweiger B; Wittke K; Grabowski P; Volk HD; Scheibenbogen C
Vaccine; 2016 May; 34(21):2417-2423. PubMed ID: 27055021
[TBL] [Abstract][Full Text] [Related]
14. Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination.
Muller RB; Maier R; Hoschler K; Zambon M; Ludewig B; Herrmann M; Schulze-Koops H; von Kempis J
Clin Exp Rheumatol; 2013; 31(5):723-30. PubMed ID: 23806224
[TBL] [Abstract][Full Text] [Related]
15. Numbers and cytotoxicities of CD3+CD56+ T lymphocytes in peripheral blood of patients with acute myeloid leukemia and acute lymphocytic leukemia.
Guo W; Xing C; Dong A; Lin X; Lin Y; Zhu B; He M; Yao R
Cancer Biol Ther; 2013 Oct; 14(10):916-21. PubMed ID: 24030391
[TBL] [Abstract][Full Text] [Related]
16. Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia.
Zhu L; Kong Y; Zhang J; Claxton DF; Ehmann WC; Rybka WB; Palmisiano ND; Wang M; Jia B; Bayerl M; Schell TD; Hohl RJ; Zeng H; Zheng H
J Hematol Oncol; 2017 Jun; 10(1):124. PubMed ID: 28629373
[TBL] [Abstract][Full Text] [Related]
17. Serial influenza-vaccination reveals impaired maintenance of specific T-cell memory in patients with end-stage renal failure.
Sester U; Schmidt T; Kuhlmann MK; Gärtner BC; Uhlmann-Schiffler H; Sester M
Vaccine; 2013 Aug; 31(38):4111-20. PubMed ID: 23845814
[TBL] [Abstract][Full Text] [Related]
18. A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia.
van de Loosdrecht AA; van Wetering S; Santegoets SJAM; Singh SK; Eeltink CM; den Hartog Y; Koppes M; Kaspers J; Ossenkoppele GJ; Kruisbeek AM; de Gruijl TD
Cancer Immunol Immunother; 2018 Oct; 67(10):1505-1518. PubMed ID: 30039426
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia.
Wendelbo Ø; Nesthus I; Sjo M; Paulsen K; Ernst P; Bruserud Ø
Cancer Immunol Immunother; 2004 Aug; 53(8):740-7. PubMed ID: 15133630
[TBL] [Abstract][Full Text] [Related]
20. Histamine dihydrochloride and low-dose interleukin-2 as post-consolidation immunotherapy in acute myeloid leukemia.
Thorén FB; Romero AI; Brune M; Hellstrand K
Expert Opin Biol Ther; 2009 Sep; 9(9):1217-23. PubMed ID: 19653866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
